Mullah Saad H, Abutarboush Rania, Moon-Massat Paula F, Saha Biswajit K, Haque Ashraful, Walker Peter B, Auker Charles R, Arnaud Francoise G, McCarron Richard M, Scultetus Anke H
Naval Medical Research Center, NeuroTrauma Department, 503 Robert Grant Avenue Silver Spring, MD 20910, USA.
Naval Medical Research Center, NeuroTrauma Department, 503 Robert Grant Avenue Silver Spring, MD 20910, USA; Uniformed Services University of the Health Sciences, Department of Surgery, Bethesda, MD 20814, USA.
Microvasc Res. 2016 Sep;107:83-90. doi: 10.1016/j.mvr.2016.06.001. Epub 2016 Jun 7.
Sanguinate, a polyethylene glycol-conjugated carboxyhemoglobin, was investigated for cerebral vasoactivity in healthy male Sprague-Dawley rats (Study 1) and for its ability to increase brain tissue oxygen pressure (PbtO2) after controlled cortical impact (CCI) - traumatic brain injury (TBI) (Study 2). In both studies ketamine-acepromazine anesthetized rats were ventilated with 40% O2. In Study 1, a cranial window was used to measure the diameters of medium - (50-100μm) and small-sized (<50μm) pial arterioles before and after four serial infusions of Sanguinate (8mL/kg/h, cumulative 16mL/kg IV), volume-matched Hextend, or normal saline. In Study 2, PbtO2 was measured using a phosphorescence quenching method before TBI, 15min after TBI (T15) and then every 10min thereafter for 155min. At T15, rats received either 8mL/kg IV Sanguinate (40mL/kg/h) or no treatment (saline, 4mL/kg/h). Results showed: 1) in healthy rats, percentage changes in pial arteriole diameter were the same among the groups, 2) in TBI rats, PbtO2 decreased from 36.5±3.9mmHg to 19.8±3.0mmHg at T15 in both groups after TBI and did not recover in either group for the rest of the study, and 3) MAP increased 16±4mmHg and 36±5mmHg after Sanguinate in healthy and TBI rats, respectively, while MAP was unchanged in control groups. In conclusion, Sanguinate did not cause vasoconstriction in the cerebral pial arterioles of healthy rats but it also did not acutely increase PbtO2 when administered after TBI. Sanguinate was associated with an increase in MAP in both studies.
对一种聚乙二醇共轭羧基血红蛋白(Sanguinate)进行了研究,在健康雄性Sprague-Dawley大鼠中研究其脑血管活性(研究1),以及在控制性皮质撞击(CCI)-创伤性脑损伤(TBI)后其增加脑组织氧分压(PbtO2)的能力(研究2)。在两项研究中,用氯胺酮-乙酰丙嗪麻醉的大鼠均用40%氧气进行通气。在研究1中,使用颅骨视窗在连续四次输注Sanguinate(8mL/kg/h,累积16mL/kg静脉注射)、等容量的Hextend或生理盐水之前和之后测量中(50-100μm)小(<50μm)软脑膜小动脉的直径。在研究2中,在TBI前、TBI后15分钟(T15)使用磷光猝灭法测量PbtO2,此后每10分钟测量一次,共测量155分钟。在T15时,大鼠接受8mL/kg静脉注射Sanguinate(40mL/kg/h)或不接受治疗(生理盐水,4mL/kg/h)。结果显示:1)在健康大鼠中,各组软脑膜小动脉直径的百分比变化相同;2)在TBI大鼠中,两组在TBI后T15时PbtO2均从36.5±3.9mmHg降至19.8±3.0mmHg,在研究的其余时间两组均未恢复;3)在健康大鼠和TBI大鼠中,Sanguinate给药后平均动脉压(MAP)分别升高16±4mmHg和36±5mmHg,而对照组MAP无变化。总之,Sanguinate不会导致健康大鼠软脑膜小动脉血管收缩,但在TBI后给药时也不会急性增加PbtO2。在两项研究中,Sanguinate均与MAP升高有关。